BIOMAT Database Logo BIOMAT Database Logo

[Letter: Cytosine arabinoside and generalized zoster]. 1973

J Huis, and P M Van Vaerenbergh, and R Kindt

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Huis, and P M Van Vaerenbergh, and R Kindt
Letter: Cytosine arabinoside for herpes zoster.
February 1974, The New England journal of medicine,
J Huis, and P M Van Vaerenbergh, and R Kindt
Cytosine arabinoside and herpes zoster.
August 1971, Lancet (London, England),
J Huis, and P M Van Vaerenbergh, and R Kindt
Cytosine arabinoside and herpes zoster.
September 1971, Lancet (London, England),
J Huis, and P M Van Vaerenbergh, and R Kindt
Cytosine arabinoside and herpes zoster.
July 1971, Lancet (London, England),
J Huis, and P M Van Vaerenbergh, and R Kindt
Cytosine arabinoside in herpes zoster.
January 1973, Lancet (London, England),
J Huis, and P M Van Vaerenbergh, and R Kindt
Cytosine arabinoside in herpes zoster.
January 1973, Lancet (London, England),
J Huis, and P M Van Vaerenbergh, and R Kindt
Disseminated herpes zoster: treatment with cytosine arabinoside.
September 1971, The Medical annals of the District of Columbia,
J Huis, and P M Van Vaerenbergh, and R Kindt
Treatment of varicella-zoster with cytosine arabinoside.
January 1969, Transactions of the Association of American Physicians,
J Huis, and P M Van Vaerenbergh, and R Kindt
Letter: neuropathy due to cytosine arabinoside.
December 1974, British medical journal,
J Huis, and P M Van Vaerenbergh, and R Kindt
[Cytosine arabinoside in the treatment of herpes zoster].
November 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!